VERO Biotech (formerly GeNO) is a biotechnology company focused on the design, development, and commercialization of inhaled nitric oxide delivery systems for patients with cardiopulmonary conditions. It provides GENOSYL systems to meet the needs of patients and critical care providers where iNO is a part of a treatment option.